University of Groningen Myeloid I kappa B alpha Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques
暂无分享,去创建一个
S. Xanthoulea | R. Rupec | M. Gijbels | P. Leenen | M. Hoeksema | D. Curfs | P. Goossens | Hofker | M. Vergouwe | G. JohannesH. | van Woezik | H. Marten | M. Winther
[1] I. van der Made,et al. Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. , 2010, Cell metabolism.
[2] Soo-Ho Choi,et al. Low Doses of Lipopolysaccharide and Minimally Oxidized Low-Density Lipoprotein Cooperatively Activate Macrophages via Nuclear Factor &kgr;B and Activator Protein-1: Possible Mechanism for Acceleration of Atherosclerosis by Subclinical Endotoxemia , 2010, Circulation research.
[3] A. Zernecke,et al. Chemokines in the vascular inflammatory response of atherosclerosis. , 2010, Cardiovascular research.
[4] K. Moore,et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.
[5] M. Karin,et al. Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.
[6] G. Kollias,et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. , 2008, Cell metabolism.
[7] Christian Weber,et al. Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series Editor : Christian Weber Chemokines in Atherosclerosis An Update , 2008 .
[8] G. Natoli,et al. Nuclear Ubiquitin Ligases, NF-κB Degradation, and the Control of Inflammation , 2008, Science Signaling.
[9] D. Teupser,et al. The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genes , 2007, Proceedings of the National Academy of Sciences.
[10] S. Gerondakis,et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.
[11] A. Tedgui,et al. Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.
[12] S. Xanthoulea,et al. Nuclear factor kappaB signaling in macrophage function and atherogenesis , 2005, Current opinion in lipidology.
[13] N. Cheshire,et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] N. Van Rooijen,et al. Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.
[15] J. Hamilton,et al. The Phenotype of Inflammatory Macrophages Is Stimulus Dependent: Implications for the Nature of the Inflammatory Response1 , 2003, The Journal of Immunology.
[16] Georg Kraal,et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.
[17] M. Cybulsky,et al. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[19] S. Nishikawa,et al. Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. , 1998, Blood.
[20] H. Kiwada,et al. Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate. , 1996, American Journal of Pathology.
[21] C. Stewart,et al. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice , 1996, Molecular and cellular biology.
[22] R. Knuechel,et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.
[23] D. Baltimore,et al. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.
[24] M. D. de Bruijn,et al. Markers of mouse macrophage development detected by monoclonal antibodies. , 1994, Journal of immunological methods.
[25] M. Flaig,et al. Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. , 2007, Immunity.
[26] B. Dörken,et al. Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. , 2005, Immunity.
[27] I. Verma,et al. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. , 2005, Nature cell biology.
[28] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.
[29] H. Pahl,et al. Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[30] F. Neumann,et al. Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. , 1997, Arteriosclerosis, thrombosis, and vascular biology.